CS logo
small CS logo
IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali

Rionero in Vulture, Potenza, Italy

About IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
No rows

Clinical Trials at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali


During the past decade, IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali


According to Clinical.Site data, the most researched conditions in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali" are "Aplastic Anemia" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Mantle Cell Lymphoma" (1 trials), "Myelodysplasia" (1 trials) and "Myelodysplastic-Myeloproliferative Diseases" (1 trials). Many other conditions were trialed in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali" in a lesser frequency.

Clinical Trials Intervention Types at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali


Most popular intervention types in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "BEAM" (1 trials), "Bendamustine, Lenalidomide, Rituximab" (1 trials), "Copanlisib" (1 trials) and "ZEVALIN" (1 trials). Other intervention names were less common.

Clinical Trials Genders at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali


The vast majority of trials in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali" are 5 trials for "All" genders.

Clinical Trials Status at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali


Currently, there are NaN active trials in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status